BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11399108)

  • 1. Increased superoxide dismutase and Down's syndrome.
    Turrens JF
    Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
    Tamarkina AD; Annenkov GA; Filippov IK; Lamchingiĭn T
    Genetika; 1977; 13(5):929-32. PubMed ID: 147797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
    Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
    Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.
    Meguid NA; Kholoussi NM; Afifi HH
    Biol Trace Elem Res; 2001 Jul; 81(1):21-8. PubMed ID: 11508329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation sensitivity of Down's syndrome fibroblasts might be due to overexpressed Cu/Zn-superoxide dismutase (EC 1.15.1.1).
    Schwaiger H; Weirich HG; Brunner P; Rass C; Hirsch-Kauffmann M; Groner Y; Schweiger M
    Eur J Cell Biol; 1989 Feb; 48(1):79-87. PubMed ID: 2526018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular exercise did not modify significantly superoxide dismutase activity in adolescents with Down's syndrome.
    Ordoñez FJ; Rosety M; Rosety-Rodriguez M
    Br J Sports Med; 2006 Aug; 40(8):717-8. PubMed ID: 16864566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell damage by excess CuZnSOD and Down's syndrome.
    Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
    Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of copper-zinc superoxide dismutase in trisomy 21.
    De La Torre R; Casado A; López-Fernández E; Carrascosa D; Ramírez V; Sáez J
    Experientia; 1996 Sep; 52(9):871-3. PubMed ID: 8841514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
    Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
    Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A boy with Down's syndrome having recombinant chromosome 21 but no SOD-1 excess.
    Miyazaki K; Yamanaka T; Ogasawara N
    Clin Genet; 1987 Dec; 32(6):383-7. PubMed ID: 2963715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and Down's syndrome.
    Arbuzova S; Hutchin T; Cuckle H
    Bioessays; 2002 Aug; 24(8):681-4. PubMed ID: 12210526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
    Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
    J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate Down's syndrome in three siblings having partial trisomy 21q22.2 to qter and therefore no SOD-1 excess.
    Habedank M; Rodewald A
    Hum Genet; 1982; 60(1):74-7. PubMed ID: 6210617
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aging of nervous system and S-100 proteins].
    Kato K; Asano T; Inagaki T; Yamamoto T; Sato T
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):287-92. PubMed ID: 2145454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative pathways might mediate toxicity of high concentrations of superoxide dismutase.
    Kowald A; Klipp E
    Ann N Y Acad Sci; 2004 Jun; 1019():370-4. PubMed ID: 15247047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia.
    Banerjee S; Smallwood A; Nargund G; Campbell S
    Placenta; 2002; 23(2-3):172-4. PubMed ID: 11945083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide dismutase (SOD) as a potential inhibitory mediator of inflammation via neutrophil apoptosis.
    Yasui K; Kobayashi N; Yamazaki T; Agematsu K; Matsuzaki S; Ito S; Nakata S; Baba A; Koike K
    Free Radic Res; 2005 Jul; 39(7):755-62. PubMed ID: 16036355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.